Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.
企業コードMMSI
会社名Merit Medical Systems Inc
上場日Sep 16, 1954
設立日1987
最高経営責任者「CEO」- -
従業員数7400
証券種類Ordinary Share
決算期末Sep 16
本社所在地1600 West Merit Park Way
都市SOUTH JORDAN
証券取引所NASDAQ Global Select Consolidated
国United States of America
郵便番号84095
電話番号18012531600
ウェブサイトhttps://www.merit.com/
企業コードMMSI
上場日Sep 16, 1954
設立日1987
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし